Total Payments
$5,663
2024 Payments
$1,082
Companies
37
Transactions
292
Medicare Patients
8,930
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$5,663 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,663 | 292 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $919.01 | 50 | $0 (2024) |
| Janssen Biotech, Inc. | $546.94 | 25 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $528.20 | 28 | $0 (2024) |
| GENZYME CORPORATION | $371.30 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $340.50 | 18 | $0 (2024) |
| LEO Pharma Inc. | $314.05 | 20 | $0 (2024) |
| Amgen Inc. | $267.51 | 13 | $0 (2024) |
| Lilly USA, LLC | $255.93 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $230.96 | 9 | $0 (2024) |
| Genentech USA, Inc. | $221.80 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,082 | 46 | GENZYME CORPORATION ($181.87) |
| 2023 | $1,286 | 64 | Janssen Biotech, Inc. ($267.20) |
| 2022 | $652.51 | 36 | ABBVIE INC. ($150.04) |
| 2021 | $284.55 | 15 | AbbVie Inc. ($127.46) |
| 2020 | $277.61 | 15 | AbbVie Inc. ($101.65) |
| 2019 | $785.46 | 41 | Genentech USA, Inc. ($138.61) |
| 2018 | $747.55 | 44 | AbbVie, Inc. ($155.99) |
| 2017 | $546.86 | 31 | Janssen Biotech, Inc. ($90.14) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $41.20 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/25/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: Immunology | ||||||
| 10/15/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Inflammation | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Inflammation | ||||||
| 09/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $28.65 | General |
| 09/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Dermatology | ||||||
| 08/29/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $9.87 | General |
| Category: Dermatology | ||||||
| 08/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Dermatology | ||||||
| 08/22/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Immunology | ||||||
| 08/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: Immunology | ||||||
| 08/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.76 | General |
| 07/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: DERMATOLOGY | ||||||
| 07/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,258 | 3,071 | $4.9M | $750,301 |
| 2022 | 34 | 2,478 | 3,474 | $4.5M | $698,227 |
| 2021 | 32 | 2,126 | 3,220 | $3.6M | $586,066 |
| 2020 | 31 | 2,068 | 3,055 | $3.4M | $547,453 |
Total Patients
8,930
Total Services
12,820
Medicare Billing
$2.6M
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 418 | 588 | $1.7M | $279,449 | 16.2% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 200 | 352 | $627,035 | $118,952 | 19.0% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 128 | 178 | $479,140 | $84,857 | 17.7% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 208 | 235 | $573,064 | $46,483 | 8.1% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 41 | 42 | $157,797 | $24,871 | 15.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 109 | 126 | $207,852 | $23,816 | 11.5% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 27 | 27 | $114,206 | $21,629 | 18.9% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 37 | 61 | $101,417 | $19,768 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 214 | 276 | $72,588 | $17,385 | 24.0% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 20 | 20 | $102,192 | $15,437 | 15.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 70 | 74 | $74,148 | $12,479 | 16.8% |
| 14301 | Repair of wound by transferring skin, 30.1-60.0 sq cm | Office | 2023 | 14 | 14 | $77,846 | $11,926 | 15.3% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 13 | 13 | $58,610 | $9,715 | 16.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 117 | 162 | $61,236 | $8,538 | 13.9% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 26 | 26 | $79,007 | $5,473 | 6.9% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 21 | 23 | $27,632 | $5,372 | 19.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 107 | 125 | $37,954 | $4,613 | 12.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 95 | 105 | $15,491 | $4,226 | 27.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 94 | $19,270 | $3,779 | 19.6% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 27 | 27 | $24,842 | $3,385 | 13.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 29 | 32 | $29,956 | $3,206 | 10.7% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 24 | 35 | $20,551 | $2,882 | 14.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 22 | 25 | $26,554 | $2,847 | 10.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 22 | 22 | $20,242 | $2,831 | 14.0% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 13 | 13 | $20,211 | $2,424 | 12.0% |
About Dr. James Twede, MD
Dr. James Twede, MD is a MOHS-Micrographic Surgery healthcare provider based in Englewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194818948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Twede, MD has received a total of $5,663 in payments from pharmaceutical and medical device companies, with $1,082 received in 2024. These payments were reported across 292 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,663).
As a Medicare-enrolled provider, Twede has provided services to 8,930 Medicare beneficiaries, totaling 12,820 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Procedural Dermatology, Dermatology
- Location Englewood, CO
- Active Since 10/02/2006
- Last Updated 05/29/2025
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1194818948
Products in Payments
- DUPIXENT (Biological) $436.94
- SKYRIZI (Biological) $368.77
- TREMFYA (Drug) $324.08
- Humira (Biological) $275.84
- Odomzo (Drug) $264.55
- TALTZ (Drug) $255.93
- Erivedge (Biological) $221.80
- OPZELURA (Drug) $192.86
- ADBRY (Biological) $182.53
- COSENTYX (Biological) $165.26
- ILUMYA (Biological) $160.12
- RINVOQ (Biological) $151.65
- REMICADE (Biological) $149.84
- Otezla (Drug) $147.69
- Enbrel (Biological) $134.28
- ENSTILAR (Drug) $119.04
- DUPIXENT (Drug) $98.21
- HUMIRA (Biological) $86.13
- JUBLIA (Drug) $82.72
- Sitavig (Drug) $77.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.